Lilly/Incyte Pill Beats Placebo in Mid-stage Eczema Trial Lilly/Incyte Pill Beats Placebo in Mid-stage Eczema Trial

Eli Lilly and Co and Incyte Corp on Thursday said a mid-stage trial of their oral drug baricitinib showed that at the highest dose it worked better than placebo for people with moderate-to-severe atopic dermatitis.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news